On January 4, 2019, Monsanto filed a motion for summary judgment and specific causation Daubert motions in the Hardeman, Stevick and Gebeyehou v. Monsanto Co. cases, each of which is pending in the MDL in the U.S. District Court for the Northern District of California before Judge Vince Chhabria. Monsanto argues in its brief that it is entitled to judgment in its favor in all of these cases because plaintiffs have failed to put forward reliable and admissible expert testimony on specific medical causation, which is essential to support their claims. In addition, Monsanto has urged the court to grant summary judgment because the claims in all of these cases are preempted by federal law and on several other grounds.
Monsanto also moved to exclude the testimony of plaintiffs’ proposed specific causation experts, Drs. Nabhan, Shustov, and Weisenburger, because their opinions – which rely on a similar and flawed differential diagnosis – fail to meet the scientific reliability requirements of Daubert.
Bayer continues to make progress on its five-point plan to manage and mitigate the risks of Roundup™ litigation in the U.S. We settled most of the claims in this litigation and have appropriately provisioned for the remaining claims. Having won most trials, the company will continue to try cases based on decades of science and worldwide regulatory assessments that continue to support Roundup’s safety and non-carcinogenicity.